97 related articles for article (PubMed ID: 19583443)
21. The 2009 A (H1N1) influenza virus pandemic: A review.
Girard MP; Tam JS; Assossou OM; Kieny MP
Vaccine; 2010 Jul; 28(31):4895-902. PubMed ID: 20553769
[TBL] [Abstract][Full Text] [Related]
22. Swine flu and pregnancy.
Toal M; Agyeman-Duah K; Schwenk A; Yoong W
J Obstet Gynaecol; 2010 Feb; 30(2):97-100. PubMed ID: 20143962
[TBL] [Abstract][Full Text] [Related]
23. [Study on evolutionary origin of influenza A virus (H1N1) based on HA gene].
Lu YH; Ju LW; Jiang LF; Yang JX; Shi Q; Jiang QW
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):553-8. PubMed ID: 19954063
[TBL] [Abstract][Full Text] [Related]
24. Antiviral drug treatment for emerging swine flu.
Wiwanitkit V
Clin Ter; 2009; 160(3):243-5. PubMed ID: 19756328
[TBL] [Abstract][Full Text] [Related]
25. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
26. Swine flu pandemic. What's old is new: 1918 virus matches 2009 H1N1 strain.
Cohen J
Science; 2010 Mar; 327(5973):1563-4. PubMed ID: 20339037
[No Abstract] [Full Text] [Related]
27. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
Liu H; Yao X; Wang C; Han J
Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
[TBL] [Abstract][Full Text] [Related]
28. Ligand and structure-based approaches for the identification of SIRT1 activators.
Vyas VK; Goel A; Ghate M; Patel P
Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
[TBL] [Abstract][Full Text] [Related]
29. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
[TBL] [Abstract][Full Text] [Related]
30. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
[TBL] [Abstract][Full Text] [Related]
31. Bird flu, swine flu, and resistant influenza: the scary development of antiviral-resistant strains-part 2: novel A(H1N1): the flu we never expected.
O'Malley P
Clin Nurse Spec; 2009; 23(6):293-5. PubMed ID: 19858899
[No Abstract] [Full Text] [Related]
32. [Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects].
Koopmans MP; Meijer A; van der Lubben MI; Boucher C; Fouchier RA; Osterhaus AD; Timen A; de Jong MD; van Steenbergen JE
Ned Tijdschr Geneeskd; 2009; 153():A770. PubMed ID: 19785811
[TBL] [Abstract][Full Text] [Related]
33. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.
Yang JR; Huang YP; Lin YC; Su CH; Kuo CY; Hsu LC; Wu HS; Liu MT
Antiviral Res; 2010 Dec; 88(3):256-62. PubMed ID: 20869989
[TBL] [Abstract][Full Text] [Related]
34. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(16):433-5. PubMed ID: 19407738
[TBL] [Abstract][Full Text] [Related]
35. Combination of pharmacophore model development and binding mode analyses: identification of ligand features essential for IκB kinase-beta (IKKβ) inhibitors and virtual screening based on it.
Sun HP; Zhu J; Chen FH; Zhang SL; Zhang Y; You QD
Eur J Med Chem; 2011 Sep; 46(9):3942-52. PubMed ID: 21708416
[TBL] [Abstract][Full Text] [Related]
36. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
Yu H; Wang Z; Zhang L; Zhang J; Huang Q
Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
[TBL] [Abstract][Full Text] [Related]
37. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
38. Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions.
Abu Hammad AM; Afifi FU; Taha MO
J Mol Graph Model; 2007 Sep; 26(2):443-56. PubMed ID: 17360207
[TBL] [Abstract][Full Text] [Related]
39. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
40. 2009 H1N1 influenza pandemic.
Woo TM
J Pediatr Health Care; 2010; 24(4):258-66; quiz 267-9. PubMed ID: 20620852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
